Elliot Turner Returns
The Business Brew
Insights into the Evolution of Life Sciences and Investments
This chapter explores the evolution of the life sciences sector, reflecting on the impact of COVID-19 and advancements in biotechnology. It emphasizes the importance of focused investing in biotech companies and the transformative potential of technologies like CRISPR in treating genetic diseases. The conversation also delves into challenges faced by companies during the pandemic, strategic decisions in the industry, and the future potential of companies like Marvai.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
